KEYWORD

dementia

UCI researchers receive $3.5 million grant to study elderly with certain type of dementia

UCI School of Medicine researchers have been awarded a five-year, $3.5 million grant from the National Institutes of Health to study a type of dementia, called hippocampal sclerosis, that often mimics Alzheimer’s disease. Led by Dr. Seyed Ahmad Sajjadi, assistant professor of neurology, the study will test the hypothesis that HS sufferers have more significant […]

The Alzheimer’s crunch

With jump in patients expected, new leader of clinical research operations at UCI MIND aims to accelerate translation of discoveries into effective treatments

Dementia developments

Co-hosted by UCI MIND, the 30th Annual Southern California Alzheimer’s Disease Research Conference will share recent discoveries

UCI study identifies a new way by which the human brain marks time

Novel findings may further understanding of age-related dementia

UCI neurobiologists aim to identify biomarkers for Alzheimer’s disease

Researchers hope to develop brain imaging tools for pre-symptomatic diagnosis

Effort to create mouse that more closely mirrors human Alzheimer’s wins federal grant

Genetically engineered model could boost anti-dementia drug research

Dr. Claudia Kawas awarded $100,000 Potamkin Prize for dementia research

The American Academy of Neurology is giving UCI’s Dr. Claudia Kawas a 2017 Potamkin Prize for Research in Pick’s, Alzheimer’s & Related Diseases for her dementia work. Sometimes referred to as the Nobel Prize of Alzheimer’s research, the $100,000 award is an internationally recognized tribute to those advancing our understanding of dementia. Kawas will be […]

Mars-bound astronauts face chronic dementia risk from galactic cosmic ray exposure

UCI study raises questions about long-term brain health after extended spaceflights

Selective retention of positive information may be marker for elderly memory loss

UCI group develops test to measure changes in emotional recall over time

Alzheimer’s: It’s Not What You Think

Claudia Kawas turns the study of the disease on its head, leading other researchers to change their assumptions